NCT04198844View on ClinicalTrials.gov

The Effectiveness and Safety of Apixaban in NVAF Patients With History of Osteoporosis and/or Fracture: A Nation-wide Population Based Study

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

November 18, 2019

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions
Atrial Fibrillation
Interventions
DRUG

warfarin

warfarin user

DRUG

apixaban

apixaban user

Trial Locations (1)

04631

Pfizer Investigational Site, Seoul

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04198844 - The Effectiveness and Safety of Apixaban in NVAF Patients With History of Osteoporosis and/or Fracture: A Nation-wide Population Based Study | Biotech Hunter | Biotech Hunter